Mark M. Mendez

Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by HubSpot, Inc. of $400 million aggregate principal amount of its 0.25% convertible senior notes due 2022,…

Davis Polk advised The Orogen Group on its $108 million strategic equity investment in newly issued convertible preferred stock of Virtusa Corporation. In connection with the investment,…

Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of $201.25 million aggregate principal amount of its 3.375% convertible…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Silicon Laboratories Inc. of $400 million aggregate principal amount of its…

Davis Polk is advising Communications Sales & Leasing, Inc. on its $170 million acquisition of Hunt Telecommunications, LLC. The initial consideration to be paid to the equity…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of $125 million aggregate principal amount of Horizon Global Corporation’s 2.75%…

Davis Polk advised NICE Systems Inc., a wholly owned subsidiary of NICE Ltd., in connection with its offering of $287.5 million aggregate principal amount of its 1.25% exchangeable senior…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $345 million aggregate principal amount of Veeco’s 2.70% convertible senior notes due 2023, which…

Davis Polk advised the sole book-running manager and initial purchaser in connection with a Rule 144A offering by Sucampo Pharmaceuticals, Inc. of $300 million aggregate principal amount of…